Seattle-area health data company Truveta announced a partnership Tuesday with biopharma giant Pfizer, which will use Truveta’s platform to monitor the safety of its COVID vaccines and therapies across the U.S. Truveta has access to de-identified data from 20 health systems, representing more than 15% of U.S. healthcare. The company also released data from a recent analysis of COVID-19, suggesting that women are more susceptible to long COVID, consistent with previous studies.  

Like what you're reading? Subscribe to GeekWire's free newsletters to catch every headline

Job Listings on GeekWork

Find more jobs on GeekWork. Employers, post a job here.